A pharmacovigilance system for treatment access and medical donation programs: The Max Foundation experience

BACKGROUND: Cancer is a major burden of disease in low- and middle-income countries (LMICs) yet financial barriers limit access to life-saving oncology drugs. Medical donation and other drug access programs can help improve patient access to essential medicines, such as quality assured oncology drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Novakowski, Ann Kim, Garcia-Gonzalez, Pat, Wrigglesworth, Michael, Stergachis, Andy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062918/
https://www.ncbi.nlm.nih.gov/pubmed/30053910
http://dx.doi.org/10.1186/s12992-018-0391-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062918/
https://www.ncbi.nlm.nih.gov/pubmed/30053910
http://dx.doi.org/10.1186/s12992-018-0391-4

Ejemplares similares